Loading...
Dual antiplatelet therapy for secondary prevention of coronary artery disease
Dual antiplatelet therapy (DAPT) combining aspirin and a P2Y(12) receptor inhibitor has been consistently shown to reduce recurrent major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI) for stable coronary art...
Na minha lista:
| Udgivet i: | Open Heart |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652612/ https://ncbi.nlm.nih.gov/pubmed/29081979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2017-000651 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|